The Vietnamese market for Penicillins and Streptomycins in dosage form has shown significant fluctuations over the past decade. Starting from 2012, the market size has generally increased, hitting a peak in 2021 before slightly declining in 2022. Initial years saw modest growth, but notable spikes occurred in 2017 and 2019. The last two years indicated a mixed trend with substantial growth in 2021 followed by a decline in 2022. The Compound Annual Growth Rate (CAGR) for the last five years leading up to 2022 was around 4.2%, indicating a relatively moderate growth trend over time.
Future trends to watch for include:
- Potential market stabilization or recovery post-2022 decline.
- Impact of new pharmaceutical regulations and healthcare policies in Vietnam.
- Technological advancements in drug formulation and distribution.
- Changes in consumer healthcare behavior post-pandemic.
How does Vietnam rank in Penicillins and Streptomycins in Dosage Market Size Value?
| # | 33 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 4,303,400,000 | 2023 | +0.61% | +1.48% | View data |
| 2 | 2 United Kingdom | 730,000,000 | 2023 | -1.31% | -1.45% | View data |
| 3 | 3 France | 717,200,000 | 2023 | -1.91% | +0.034% | View data |
| 4 | 4 Italy | 622,330,000 | 2023 | -3.96% | -4.86% | View data |
| 5 | 5 Germany | 476,270,000 | 2023 | +1.03% | +1.1% | View data |
| 6 | 6 Brazil | 451,970,000 | 2023 | +1.29% | -0.21% | View data |
| 7 | 7 Australia | 260,610,000 | 2023 | +1.79% | +1.42% | View data |
| 8 | 8 Vietnam | 256,220,000 | 2023 | +4.62% | +6.03% | |
| 9 | 9 Canada | 209,600,000 | 2023 | -2.3% | +1.59% | View data |
| 10 | 10 Spain | 197,590,000 | 2023 | -1.96% | -2.19% | View data |
